Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Seong Il Seo
Affiliation
Samsung Medical Center, Sungkyunkwan University School of Medicine
ORCID
Career Start Year
1999
Papers
224
H Index
32
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37118959
Nomogram Using Prostate Health Index for Predicting Prostate Cancer in the Gray Zone: Prospective, Multicenter Study.
World J Mens Health
2024
38000052
Impact of urinary diversion type on urethral recurrence following radical cystectomy for bladder cancer: propensity score matched and weighted analyses of retrospective cohort.
Int J Surg
2024
36254631
Repression of SLC22A3 by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancer.
FEBS J
2023
37668199
How far has robot-assisted partial nephrectomy reached?
Investig Clin Urol
2023
37745907
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer.
Prostate Int
2023
37509551
Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer.
Biomedicines
2023
37444526
Novel Multiparametric Magnetic Resonance Imaging-Based Deep Learning and Clinical Parameter Integration for the Prediction of Long-Term Biochemical Recurrence-Free Survival in Prostate Cancer after Radical Prostatectomy.
Cancers (Basel)
2023
37409092
Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy.
Prostate Int
2023
37376735
Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study.
J Yeungnam Med Sci
2023
36716293
CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy.
Clin Cancer Res
2023
36835404
Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Int J Mol Sci
2023
36929129
New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles' operation.
Insights Imaging
2023
36167777
Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy.
Eur Urol Focus
2023
35141158
TRUS-Guided Target Biopsy for a PI-RADS 3-5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis.
Front Oncol
2022
35510096
Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1-2 on multiparametric magnetic resonance imaging.
Prostate Int
2022
35675311
Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.
PLoS One
2022
35574412
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.
Front Oncol
2022
35626196
Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer.
Diagnostics (Basel)
2022
35626101
Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study.
Cancers (Basel)
2022
35625960
Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma.
Cancers (Basel)
2022
36293494
Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma.
Int J Mol Sci
2022
36291981
A Comparison of Functional and Oncologic Outcomes between Partial Nephrectomy and Radiofrequency Ablation in Patients with Chronic Kidney Disease after Propensity Score Matching.
Diagnostics (Basel)
2022
36077710
Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions.
Cancers (Basel)
2022
33857365
Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma.
Cancer Res Treat
2022
33047324
Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome.
J Surg Oncol
2021
33923583
Pattern of Tumor-Infiltrating Lymphocytes in Mixed Epithelial and Stromal Tumor of the Kidney: A Review of Five Cases.
Cells
2021
33692449
Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma.
Sci Rep
2021
33837237
Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma.
Sci Rep
2021
33527588
Targeted therapy response in early versus late recurrence of renal cell carcinoma after surgical treatment: A propensity score-matched study using the Korean Renal Cancer Study Group database.
Int J Urol
2021
33660451
Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance.
Investig Clin Urol
2021
33916347
Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities.
Biology (Basel)
2021
34944964
Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer.
Cancers (Basel)
2021
34753990
ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT).
Sci Rep
2021
34753938
Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels.
Sci Rep
2021
34692504
Conditional Intravesical Recurrence-Free Survival Rate After Radical Nephroureterectomy With Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Front Oncol
2021
34397846
Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model.
Medicine (Baltimore)
2021
34839812
A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.
BMC Cancer
2021
34768437
Preoperative versus Postoperative Compensation of the Contralateral Normal Kidney in Patients Treated with Radical Nephrectomy for Renal Cell Carcinoma.
J Clin Med
2021
34768322
The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy.
J Clin Med
2021
33939714
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.
PLoS One
2021
34071865
Renal Cell Carcinoma-Infiltrating CD3<sup>low</sup> Vγ9Vδ1 T Cells Represent Potentially Novel Anti-Tumor Immune Players.
Curr Issues Mol Biol
2021
34262353
Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?
Cancer Manag Res
2021
34235097
Comparison of Risk Factors for the Development of Proteinuria After Radical Nephrectomy for Renal Cell Carcinoma.
Res Rep Urol
2021
33421984
Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Cancer Res Treat
2021
31621405
Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors.
J Endourol
2020
31987989
Functions of human liver CD69<sup>+</sup>CD103<sup>-</sup>CD8<sup>+</sup> T cells depend on HIF-2α activity in healthy and pathologic livers.
J Hepatol
2020
33193883
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis.
J Cancer
2020
33135403
Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL.
Investig Clin Urol
2020
33107227
Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL).
J Korean Med Sci
2020
33102394
Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients.
Prostate Int
2020
1 - 50 of 224
Column Actions
Search
Recommended Authors
Giovanni Motterle
Mayo Clinic
Career Start Year
2017
Number of shared co-authors
0
Jiayu Liang
institute of urology
Career Start Year
2016
Number of shared co-authors
0
Saum Ghodoussipour
Rutgers Cancer Institute of New Jersey
Career Start Year
2016
Number of shared co-authors
1
Jamil S Syed
Yale School of Medicine
Career Start Year
2015
Number of shared co-authors
0
Yue Yang
Institute of Cancer Prevention and Treatment, Harbin Medical University
Career Start Year
2015
Number of shared co-authors
0
Riccardo Campi
Careggi University Hospital
Career Start Year
2014
Number of shared co-authors
0
Zeyad R Schwen
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year
2013
Number of shared co-authors
0
David C Johnson
University of North Carolina School of Medicine
Career Start Year
2012
Number of shared co-authors
0
Shinji Ohtake
Institute of Urologic Oncology, University of California los angeles
Career Start Year
2010
Number of shared co-authors
0
Izak Faiena
Columbia University Medical Center
Career Start Year
2010
Number of shared co-authors
0
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Joseph Brito
Yale School of Medicine
Career Start Year
2008
Number of shared co-authors
0
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Career Start Year
2008
Number of shared co-authors
0
Amirali Salmasi
University of California San Diego
Career Start Year
2005
Number of shared co-authors
0
Paul L Crispen
University of Florida
Career Start Year
2005
Number of shared co-authors
0
Jonathan L Wright
University of Washington Medical Center
Career Start Year
2005
Number of shared co-authors
0
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year
2004
Number of shared co-authors
0
Lin Qi
Xiangya Hospital of Central South University
Career Start Year
2003
Number of shared co-authors
1
Brian A Costello
The Mayo Clinic
Career Start Year
2001
Number of shared co-authors
0
Karim Chamie
David Geffen School of Medicine at university of california los angeles
Career Start Year
2001
Number of shared co-authors
0
Robert Jeffrey Karnes
Mayo Clinic
Career Start Year
2000
Number of shared co-authors
0
Ithaar H Derweesh
university of california san diego School of Medicine
Career Start Year
2000
Number of shared co-authors
1
Hak J Lee
university of california san diego School of Medicine
Career Start Year
1998
Number of shared co-authors
1
Todd M Morgan
University of Michigan ann arbor
Career Start Year
1997
Number of shared co-authors
1
Surena F Matin
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Omer Acar
University of Illinois at Chicago
Career Start Year
1996
Number of shared co-authors
0
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year
1994
Number of shared co-authors
0
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year
1993
Number of shared co-authors
0
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year
1984
Number of shared co-authors
0
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year
1981
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
162
Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
154
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers
24
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Co-authored papers
21
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers
15
Seok-Soo Byun
Seoul National University Bundang Hospital
Co-authored papers
12
Ji Youl Lee
Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Co-authored papers
9
Yong Hyun Park
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Co-authored papers
8
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers
7
Seok Soo Byun
Seoul National University Bundang Hospital
Co-authored papers
7
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers
5
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers
5
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Co-authored papers
4
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Co-authored papers
3
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers
3
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
2
In Young Choi
The Catholic University of Korea College of Medicine
Co-authored papers
2
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers
2
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers
1
Sun Jung Lee
College of Medicine, The Catholic University of Korea
Co-authored papers
1
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers
1
Sung Hye Yu
College of Medicine, Catholic University of Korea
Co-authored papers
1
Kyung Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
1
Min Gew Choi
Research Institute, National Cancer Center
Co-authored papers
1
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
1
David I Quinn
USC Norris Comprehensive Cancer Center
Co-authored papers
1
Yejin Kim
University of Texas Health Science Center at Houston
Co-authored papers
1
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers
1
Kyoung-Mee Kim
Seoul National University College of Medicine
Co-authored papers
1
Kyunga Kim
Co-authored papers
1
1 - 30